Sovegna

850 East 300 South, Unit 1, Salt Lake City, UT 84102

Sovegna is an outpatient facility in Salt Lake City, UT offering substance use treatment and detox. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment.

Licenses and accreditations

Drug Enforcement Agency (DEA)Registered with the Drug Enforcement Administration.
State substance use treatment agencyLicensed by the state's substance use treatment agency.

Kinds of care

Detoxification: Medical care while the body clears a substance, with staff watching for withdrawal.
Substance use treatment: Treatment for alcohol and drug use.
Treatment for co-occurring disorders plus serious emotional disturbance (SED) in children: Treats substance use together with a serious emotional disturbance in children and adolescents.
Treatment for co-occurring disorders plus serious mental illness (SMI) in adults: Treats substance use together with a serious mental illness in adults.

Settings

Outpatient: Regular appointments while living at home.
Outpatient detoxification: Detox during the day, going home at night.
Outpatient methadone/buprenorphine or naltrexone treatment: Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
Regular outpatient treatment: Weekly or less frequent appointments while living at home.

Medications for opioid use

Buprenorphine used in Treatment: Buprenorphine is used here.
Naltrexone used in Treatment: Naltrexone is used here.

Accepts clients using MAT but prescribed elsewhere: Accepts clients whose medication for opioid use is prescribed elsewhere.
Buprenorphine maintenance: Buprenorphine continued over time to prevent relapse.
Lofexidine or Clonidine detoxification: Lofexidine or clonidine to ease withdrawal during detox.
Prescribes buprenorphine: Prescribes buprenorphine.
Prescribes naltrexone: Prescribes naltrexone.

Payment

Accepted: Cash or self-payment.

Who they serve

Ages served: Adults, 26 to 64; Children and adolescents, 17 or younger; Seniors, 65 and older; Young adults, 18 to 25.
Sex: Female; Male.
Programs for: Adolescents; Adult men; Adult women; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced sexual abuse; Clients who have experienced trauma; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Seniors or older adults; Young adults.

More details this facility reports

External Opioid Medications Source: In-network prescribing entity.
Type of Alcohol Use Disorder Treatment: This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment: In-network prescribing entity; No formal relationship with prescribing entity.
Pharmacotherapies: Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Disulfiram; Lofexidine; Medication for mental disorders; Medications for pre-exposure to prophylaxis; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement; Non-nicotine smoking/tobacco cessation.
Treatment Approaches: 12-step facilitation; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling.
Facility Operation (e.g., Private, Public): Private for-profit organization.
Assessment/Pre-treatment: Complete medical history/physical exam; Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Professional interventionist/educational consultant; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
Testing: Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; STD testing; TB screening; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
Transitional Services: Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Recovery Support Services: Mentoring/peer support.
Other Services: Treatment for gambling disorder; Treatment for other addiction disorder.
Detoxification (medical withdrawal) Services: Alcohol Detoxification; Benzodiazepines Detoxification; Cocaine Detoxification; Medication routinely used during detoxification; Methamphetamines detoxification; Opioids detoxification.
Education and Counseling Services: Family counseling; Group counseling; HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Marital/couples counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
Facility Smoking Policy: Smoking permitted in designated area.
Facility Vaping Policy: Vaping permitted in designated area.
Ancillary Services: Integrated primary care services; Mental health services; Suicide prevention services.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.